FDA OKs Pembrolizumab for Adjuvant Treatment of NSCLC ...Middle East

Medscape - News
The agency expanded the indication for pembrolizumab to the adjuvant setting for patients with stage IB-IIIA NSCLC following surgery and platinum-based chemo. FDA Approvals

Hence then, the article about fda oks pembrolizumab for adjuvant treatment of nsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Pembrolizumab for Adjuvant Treatment of NSCLC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
myMOTHERLODE - before 3 hours & 38 minute